Sentences with phrase «biotechnology company advanced»
Robert Lanza, vice president of medical and scientific development at the privately - held biotechnology company Advanced Cell Technology (ACT), says that without scientific data, he is extremely skeptical of the group's claim.
https://www.scientificamerican.com/ Not exact matches
In November 2001, scientists from Advanced Cell Technologies, a biotechnology company in Massachusetts, announced that they had cloned the first human embryos for the purpose of advancing therapeutic research.
Advanced Cell Technology (ACT), the biotechnology company in Marlborough, Massachusetts, of which Lanza is chief scientific officer, had for more than a year been operating in the shadow of Geron, a rival company in Menlo Park, California.
This year like all others, scientists want to work at companies that keep innovation front and center, and the top 20 employers in 2015 include those biotechnology and pharmaceutical firms on the leading edge of these advances.
His company, GrassRoots Biotechnology, has acquired the patent for UPB1, and plans to use it to further explore root development, with the goal of producing even more advanced biofuel crops.
The letter was written and circulated by researchers Robert Lanza and Michael West of Advanced Cell Technology, a biotechnology company in Worcester, Massachusetts.
NEW YORK, August 29, 2016 — The Cancer Research Institute (CRI), a nonprofit organization dedicated to fueling the discovery and development of immunotherapies for all forms of cancer, announced today that it will honor biotechnology company Amgen with the 2016 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research at its September gala in New York City.
Advanced Cell Technology, a Santa Monica - based biotechnology company, is seeking FDA approval to use such derived cells to treat Stargardt's macular dystrophy, after studies in rats showed that the cells could restore vision.
Advanced Cell Technology, a biotechnology company based in Santa Monica., Calif., said the research should begin early next year, following the green light from the U.S. Food and Drug Administration.
This is a huge vote of confidence in the biotechnology center model of bringing nonprofit organizations and start - up life science companies together that will help advance our mission, and benefit the entire cancer community,» said Block.
The Cancer Research Institute announced today that it will honor biotechnology company Genentech and real estate developer and philanthropist Bruce Ratner with the 2017 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research.
Invivoscribe Technologies Inc. is a privately held biotechnology company dedicated to improving the quality of healthcare worldwide by providing high quality, reliable, cutting - edge reagents, tests, and bioinformatics tools to advance the fields of personalized molecular diagnostics ® and personalized molecular medicine.
The company's strategy is to expand the business into the life sciences arena, where nanotechnology and biotechnology intersect This involves the combination of core technologies in areas such as low temperature, high magnetic field and ultra-high vacuum environments; Nuclear Magnetic Resonance; X-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; advanced growth, deposition and etching.
Instant Chemistry is a biotechnology company formed in 2013 that believes scientific advances in genomics can be used in the dating industry.
Many of these funds also focus on biotechnology and the companies that make pioneering advances in this industry.
Foley Hoag, a leading law firm with offices in Boston, Washington, D.C., New York and Paris, represents biotechnology, pharmaceutical, medical device, advanced diagnostic, and health care companies regulated by the Food and Drug Administration (FDA).
The Warsaw office of Noerr has advised PFR Life Science, a subsidiary of the Polish Development Fund, which supports infrastructure and advanced technology projects, on its PLN 38.3 million investment in Mabion S.A., a biotechnology company in Poland.